Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The STIM1–TRPC1 complex is a fundamental component of the store-operated calcium entry (SOCE) machinery, a process essential for maintaining intracellular calcium homeostasis. Stromal interaction molecule 1 (STIM1) functions as a calcium sensor within the endoplasmic reticulum (ER) lumen; upon depletion of ER calcium stores, STIM1 undergoes a conformational change, oligomerizes, and translocates to ER-plasma membrane junctions [1, 3]. At these junctions, STIM1 physically interacts with and activates the Transient receptor potential cation channel subfamily C member 1 (TRPC1), often in coordination with Orai1, to facilitate the influx of extracellular calcium [2, 5]. This calcium entry is vital for diverse physiological processes, including gene transcription, cell cycle progression, and contractile function in muscle cells [4, 6]. Dysregulation of the STIM1–TRPC1 complex is heavily implicated in various pathologies, such as cardiac hypertrophy, where overactive SOCE drives pathological remodeling, and in several cancers where it promotes tumor cell migration and survival [2, 7]. Consequently, this complex represents a significant therapeutic target, with research focusing on small-molecule inhibitors that can selectively disrupt the STIM1–TRPC1 interaction or block the resulting calcium current to treat inflammatory and proliferative diseases [8].
Inhibition of store-operated calcium entry by blocking the physical interaction between STIM1 and TRPC1 or by direct antagonism of the TRPC1 channel pore [8, 10].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stromal interaction molecule 1–Transient receptor potential cation channel subfamily C member 1 complex (STIM1–TRPC1).